arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Alphatec Holdings, Inc.

ATEC
$7.78 ▼ -0.51 (-6.15%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

Alphatec Holdings, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.2B
Dividend Yield —
Revenue Growth 25.0% ↘
Op. Margin -10.7% ↗
ROIC -14.2% ↗
FCF / Share $0.02 ↗
Trailing P/E —
Price / Book 94.1x
FCF Yield 0.2%
Debt / Equity 50.74
info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$764.15M
↑ +25.0% —
Net Income Profit after all expenses
$-143.36M
↑ +11.6% —
Operating Margin Operating profit as % of sales
-10.7%
↑ +51.7% 14th
FCF / Share Free cash flow per share
$0.02
↑ +102.1% —
Long-Term Debt Long-term obligations
$565.94M
↓ -1.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
17
Financial Health ↑
22
Cash Quality
21

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 69 quarters